文献速递炎症性肠病

炎症性肠病中血栓栓塞性疾病的遗传风险患病率及效应

Prevalence and Effect of Genetic Risk of Thromboembolic Disease in Inflammatory Bowel Disease.
PubMed 文献 · Gastroenterology · 2020-10-21

该研究利用全外显子组测序和全基因组基因分型,在792例炎症性肠病(IBD)患者中评估血栓栓塞性疾病(TED)的遗传高风险比例及其与TED事件的关联。结果显示15.4%的IBD患者为遗传高风险,遗传风险与TED事件显著相关(比值比2.5,P=0.0036),且单基因与多基因风险存在叠加效应(P=0.0048)。

要点

  • 792例IBD患者中15.4%为TED遗传高风险。
  • 遗传高风险与TED事件相关,比值比2.5(P=0.0036)。
  • 单基因与多基因风险对TED有叠加效应(P=0.0048)。

核心结论

  • 遗传风险(多基因和单基因)与TED病史显著相关。
  • 遗传特征可识别约七分之一的IBD患者,其TED风险为2.5倍或更高。

研究设计与样本

  • 利用全外显子组测序和全基因组基因分型计算TED多基因风险评分并提取血栓形成倾向致病性变异。
  • 共792例IBD患者同时具有全外显子组测序和基因分型数据。
  • 遗传高风险定义为TED多基因风险评分高或携带至少1个血栓形成倾向致病性变异。

主要发现

  • 792例IBD患者中122例(15.4%)为TED遗传高风险。
  • 792例中715例有TED状态记录,其中63例(8.8%)发生TED事件。
  • 遗传TED风险与TED事件增加显著相关(比值比2.5;P=0.0036)。
  • 单基因和多基因风险对TED有叠加效应(P=0.0048)。
  • 高遗传风险患者更常见多部位血栓形成(78% vs 42%,比值比3.96;P=0.048)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The largest cause of mortality in patients with inflammatory bowel disease (IBD) remains thromboembolic disease (TED). Recent reports have demonstrated that both monogenic and polygenic factors contribute to TED and 10% of healthy subjects are genetically at high risk for TED. Our aim was to utilize whole-exome sequencing and genome-wide genotyping to determine the proportion of IBD patients genetically at risk for TED and investigate the effect of genetic risk of TED in IBD. METHODS: The TED polygenic risk score was calculated from genome-wide genotyping. Thrombophilia pathogenic variants were extracted from whole-exome sequencing. In total, 792 IBD patients had both whole-exome sequencing and genotyping data. We defined patients at genetically high risk for TED if they had a high TED polygenic risk score or carried at least 1 thrombophilia pathogenic variant. RESULTS: We identified 122 of 792 IBD patients (15.4%) as genetically high risk for TED. Among 715 of 792 subjects whose documented TED status were available, 63 of the 715 patients (8.8%) had TED events. Genetic TED risk was significantly associated with increased TED event (odds ratio, 2.5; P = .0036). In addition, we confirmed an additive effect of monogenic and polygenic risk on TED (P = .0048). Patients with high TED genetic risk more frequently had thrombosis at multiple sites (78% vs 42%, odds ratio, 3.96; P = .048). CONCLUSIONS: Genetic risk (both poly- and monogenic) was significantly associated with TED history. Our results suggest that genetic traits identify approximately 1 in 7 patients with IBD who will experience 2.5-fold or greater risk for TED.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Naito T, Botwin GJ, Haritunians T, et al. Prevalence and Effect of Genetic Risk of Thromboembolic Disease in Inflammatory Bowel Disease. Gastroenterology. 2020. PMID: 33098885. doi:10.1053/j.gastro.2020.10.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。